GlassScriptPhysician profile
Amy C Franklin
NPI 1710963756
$1,988.71
in general payments reported to CMS, 2019-2025
24 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $626 · 2023: $422 · 2024: $448 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $379.65 | 2021-2024 | |
| Astellas Pharma US INC | $376.54 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $204.72 | 2023-2025 | Myfembree, Gemtesa |
| Scynexis, INC. | $146.27 | 2022 | |
| Organon LLC | $107.88 | 2022-2025 | Nexplanon |
| Aspira Women'S Health INC | $97.59 | 2022 | |
| Millicent US INC | $83.81 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $82.76 | 2022-2023 | |
| Pfizer INC. | $72.88 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $61.08 | 2021-2023 | |
| Ethicon US, LLC | $49.73 | 2021-2022 | |
| Myovant Sciences INC. | $42.83 | 2021-2022 | |
| Exeltis, USA INC. | $37.36 | 2022-2024 | Slynd |
| Sage Therapeutics, LLC | $33.58 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $30.86 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $29.85 | 2025 | Novasure |
| Agile Therapeutics, INC. | $25.52 | 2021-2022 | |
| Conmed Corporation | $23.82 | 2024 | Airseal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.78 | 2023 | Xifaxan, Trulance |
| Pacira Pharmaceuticals Incorporated | $20.77 | 2023 | Exparel |
| Shield Therapeutics INC | $16.98 | 2025 | |
| Evofem Biosciences, INC. | $15.10 | 2021 | |
| Baxter Healthcare | $13.54 | 2022 | |
| Amgen INC. | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.